HER2 Support Group Forums - View Single Post - ASCO over--reports to follow--sorry for the "silence" (computer in the shop 4 fixing)

06-10-2010, 08:43 AM

What the abstract says to me is that with the use of Herceptin, HR+/Her2+ tumors have now jumped over the pack and have the best prognosis and are followed by HR+/Her2- tumors on the scale (these used to be the best type, as we all recall). HR-/Her2+ are 3rd on the prognostic scale. So, even the HR- tumors that are Her2+ are looking better than they would have without Herceptin. My guess is triple negative will jump up the ladder with the PARP inhibitors. That's the plan, the science should keep improving so that we all keep leap-frogging ahead and things look better for all of us. I'm looking forward to more good news from ASCO.

06-10-2010, 08:43 AM	#10
Unregistered Guest Posts: n/a	Re: ASCO over--reports to follow--sorry for the "silence" (computer in the shop 4 fix What the abstract says to me is that with the use of Herceptin, HR+/Her2+ tumors have now jumped over the pack and have the best prognosis and are followed by HR+/Her2- tumors on the scale (these used to be the best type, as we all recall). HR-/Her2+ are 3rd on the prognostic scale. So, even the HR- tumors that are Her2+ are looking better than they would have without Herceptin. My guess is triple negative will jump up the ladder with the PARP inhibitors. That's the plan, the science should keep improving so that we all keep leap-frogging ahead and things look better for all of us. I'm looking forward to more good news from ASCO.